86 related articles for article (PubMed ID: 9531280)
1. Inhibition of an in vitro CD4+ T cell alloresponse using altered peptide ligands.
Daniel C; Grakoui A; Allen PM
J Immunol; 1998 Apr; 160(7):3244-50. PubMed ID: 9531280
[TBL] [Abstract][Full Text] [Related]
2. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.
Tao X; Grant C; Constant S; Bottomly K
J Immunol; 1997 May; 158(9):4237-44. PubMed ID: 9126985
[TBL] [Abstract][Full Text] [Related]
3. TCR-independent pathways mediate the effects of antigen dose and altered peptide ligands on Th cell polarization.
Grakoui A; Donermeyer DL; Kanagawa O; Murphy KM; Allen PM
J Immunol; 1999 Feb; 162(4):1923-30. PubMed ID: 9973460
[TBL] [Abstract][Full Text] [Related]
4. Viral peptide specific induction of MHC class II expression by murine T cell clones.
Thomas DB; Smith CA; Graham CM
J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
[TBL] [Abstract][Full Text] [Related]
5. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas.
Evavold BD; Williams SG; Hsu BL; Buus S; Allen PM
J Immunol; 1992 Jan; 148(2):347-53. PubMed ID: 1370311
[TBL] [Abstract][Full Text] [Related]
6. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
Tamura T; Ariga H; Kinashi T; Uehara S; Kikuchi T; Nakada M; Tokunaga T; Xu W; Kariyone A; Saito T; Kitamura T; Maxwell G; Takaki S; Takatsu K
Int Immunol; 2004 Dec; 16(12):1691-9. PubMed ID: 15477229
[TBL] [Abstract][Full Text] [Related]
7. Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands.
Guyver CJ; Copland DA; Calder CJ; Sette A; Sidney J; Dick AD; Nicholson LB
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2027-35. PubMed ID: 16639012
[TBL] [Abstract][Full Text] [Related]
8. Elucidation and role of critical residues of immunodominant peptide associated with T cell-mediated parasitic disease.
Hernandez HJ; Stadecker MJ
J Immunol; 1999 Oct; 163(7):3877-82. PubMed ID: 10490987
[TBL] [Abstract][Full Text] [Related]
9. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells.
Aloisi F; Penna G; Polazzi E; Minghetti L; Adorini L
J Immunol; 1999 Feb; 162(3):1384-91. PubMed ID: 9973393
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities.
Robertson JM; Evavold BD
J Immunol; 1999 Aug; 163(4):1750-4. PubMed ID: 10438905
[TBL] [Abstract][Full Text] [Related]
11. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.
Munder M; Eichmann K; Modolell M
J Immunol; 1998 Jun; 160(11):5347-54. PubMed ID: 9605134
[TBL] [Abstract][Full Text] [Related]
12. TCR recognition of the Hb(64-76)/I-Ek determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity.
Hsu BL; Donermeyer DL; Allen PM
J Immunol; 1996 Sep; 157(6):2291-8. PubMed ID: 8805626
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera.
Casares S; Stan AC; Bona CA; Brumeanu TD
Nat Biotechnol; 2001 Feb; 19(2):142-7. PubMed ID: 11175728
[TBL] [Abstract][Full Text] [Related]
14. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
Marzo AL; Lake RA; Robinson BW; Scott B
Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
[TBL] [Abstract][Full Text] [Related]
15. CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR.
Leitenberg D; Boutin Y; Constant S; Bottomly K
J Immunol; 1998 Aug; 161(3):1194-203. PubMed ID: 9686579
[TBL] [Abstract][Full Text] [Related]
16. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
[TBL] [Abstract][Full Text] [Related]
17. Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signals.
Ariga H; Shimohakamada Y; Nakada M; Tokunaga T; Kikuchi T; Kariyone A; Tamura T; Takatsu K
Immunology; 2007 Oct; 122(2):210-21. PubMed ID: 17490433
[TBL] [Abstract][Full Text] [Related]
18. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
[TBL] [Abstract][Full Text] [Related]
19. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
20. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
